Humanized Rodent Models for Cancer Research

Huimin Tian; Yanan Lyu; Yong-Guang Yang; Zheng Hu

doi:10.3389/fonc.2020.01696

Humanized Rodent Models for Cancer Research

Front Oncol. 2020 Sep 11:10:1696. doi: 10.3389/fonc.2020.01696. eCollection 2020.

Authors

Huimin Tian^{1

2}, Yanan Lyu^{1

2}, Yong-Guang Yang^{1

2

3}, Zheng Hu^{1

2}

Affiliations

¹ Key Laboratory of Organ Regeneration & Transplantation of Ministry of Education, The First Hospital of Jilin University, Changchun, China.
² National-Local Joint Engineering Laboratory of Animal Models for Human Diseases, Changchun, China.
³ International Center of Future Science, Jilin University, Changchun, China.

Abstract

As one of the most popular laboratory animal models, rodents have been playing crucial roles in mechanistic investigations of oncogenesis as well as anticancer drug or regimen discoveries. However, rodent tumors show different or no responses to therapies against human cancers, and thus, in recent years, increased attention has been given to mouse models with xenografted or spontaneous human cancer cells. By combining with the human immune system (HIS) mice, these models have become more sophisticated and robust, enabling in vivo exploration of human cancer immunology and immunotherapy. In this review, we summarize the pros and cons of these humanized mouse models, with a focus on their potential as an in vivo platform for human cancer research. We also discuss the strategies for further improving these models.

Keywords: cancer; humanized mice; immunology; immunotherapy; rodent.

Publication types

Review